Choong ANG Vaccine Laboratory중앙백신
072020 · KOSDAQ · ₩072020 · 중앙백신
- Market cap
- ₩81B
- Enterprise value
- ₩61B
- P/E
- 12.0×
- P/B
- 0.8×
- Dividend yield
- 0.0%
- ROE
- 6.3%
- Net margin
- 14.0%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−15.2% from the high
₩8,560Today: ₩8,760 – ₩8,880₩10,350
Returns
- 1W−1.8%
- 1M−4.0%
- 3M−3.0%
- 6M−11.0%
- YTD−10.4%
- 1Y−9.0%
- Volume today
- 3,219
- 0.5× the 20-day average
- Traded today
- ₩28M
- Listed shares
- 9,256,781
- EPS (12 months)
- ₩731
- Earnings yield 8.3%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 34 of 100 (50 is a normal day for this stock).
- MomentumFlat-4% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Choong ANG Vaccine Laboratory stock overview
Choong ANG Vaccine Laboratory (중앙백신, KRX: 072020) is listed on KOSDAQ, in the Biotech & Pharma sector. The company develops, manufactures and sells animal vaccines and other veterinary medicines in South Korea, covering pig, poultry, companion animal, cattle and cat vaccines, along with feed additives and related biological services. Its shares closed at ₩8,780 on Oct 27, 2026, down 0.23% on the day, giving it a market value of ₩81B.
Key facts
- Market cap
- ₩81B
- Sector
- Biotech & Pharma
- Latest price change
- −0.23%
- As of
- Oct 27, 2026
- Main business
- The company develops, manufactures and sells animal vaccines and other veterinary medicines in South Korea, covering pig, poultry, companion animal, cattle and cat vaccines, along with feed additives and related biological services.
Quick answers about Choong ANG Vaccine Laboratory
- What does Choong ANG Vaccine Laboratory do?
- The company develops, manufactures and sells animal vaccines and other veterinary medicines in South Korea, covering pig, poultry, companion animal, cattle and cat vaccines, along with feed additives and related biological services. Its customers include livestock farms and pet owners, and it sells domestically and exports to markets such as Southeast Asia, the Middle East, South America, China and Africa.
- What is the market cap of Choong ANG Vaccine Laboratory?
- The market capitalisation of Choong ANG Vaccine Laboratory was ₩81B at the close on Oct 27, 2026.
- Who are the largest shareholders of Choong ANG Vaccine Laboratory?
- According to the latest official filings, the largest reported holders are Yoon In-jung (35.69%, as of Jun 15, 2026); Yoon Seok-in (7.73%, as of Apr 28, 2026); Kim Eun-hee (2.30%, as of Apr 29, 2026).
- When is the next earnings report from Choong ANG Vaccine Laboratory?
- Korean companies rarely announce results dates in advance. Based on when Choong ANG Vaccine Laboratory filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company develops, manufactures and sells animal vaccines and other veterinary medicines in South Korea, covering pig, poultry, companion animal, cattle and cat vaccines, along with feed additives and related biological services. Its customers include livestock farms and pet owners, and it sells domestically and exports to markets such as Southeast Asia, the Middle East, South America, China and Africa.
Written by AI from the company's latest annual report.
- Korean name
- 중앙백신
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 윤인중, 윤석인 (각자대표이사)
- Founded
- Oct 1994
- Listed
- Oct 2003
- Listed shares
- 9,256,781
- Fiscal year ends
- Month 12
- Website
- www.cavac.co.kr
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Entry into Liquidity Provision AgreementAug 18, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- Insider shareholding reportAug 6, 2026
- Preliminary earningsAug 5, 2026
- Major sales or supply contractJul 8, 2026
Titles in Korean until English translations are added.
Also known as: Choong ANG Vaccine Laboratory / 중앙백신 / 072020 / KRX:072020
Source: KRX statistical information